PRECIGEN INC (PGEN:NASDAQ)
$4.75 -0.05 (-1.0417%)
Analysed PRECIGEN INC (PGEN:NASDAQ) News Sources
Precigen (PGEN): The Best Penny Stock to Buy for Long Term
22-05-2026
yahoo.com
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
26-05-2026
yahoo.com
Spotlight On 3 Growth Companies With Strong Insider Stakes
26-05-2026
yahoo.com
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
30-05-2026
yahoo.com
Precigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy?
01-06-2026
yahoo.com
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices
11-06-2026
yahoo.com
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?
12-06-2026
fool.com
Precigen (PGEN) Stock Valuation Check As High P/B Multiple Meets Large DCF Upside Estimate
14-06-2026
yahoo.com
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
15-06-2026
yahoo.com
H.C. Wainwright Remains a Buy on Precigen (PGEN)
16-06-2026
yahoo.com
What is the current price of PRECIGEN INC (PGEN:NASDAQ)?
The current price of PRECIGEN INC (PGEN:NASDAQ) is $4.75.
PRECIGEN INC (PGEN:NASDAQ) absolute price change since previous trading day?
The absolute price change of PRECIGEN INC (PGEN:NASDAQ) since the previous trading day is $-0.05.
PRECIGEN INC (PGEN:NASDAQ) percentage price change since previous trading day?
The percentage price change of PRECIGEN INC (PGEN:NASDAQ) since the previous trading day is -1.0417%.
What is the most recent average sentiment score for PRECIGEN INC (PGEN:NASDAQ)?
The most recent average sentiment score for PRECIGEN INC (PGEN:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for PRECIGEN INC (PGEN:NASDAQ)?
The most recent sentiment for PRECIGEN INC (PGEN:NASDAQ) is .
SEC-8K** Filing Available For PRECIGEN INC (PGEN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.